Ligand Pharmaceuticals reported $36.3M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Amgen AMGN:US $ 14842M 257M
Anika Therapeutics ANIK:US $ 28.77M 12.6M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Baxter International BAX:US $ 3441M 97M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Clovis Oncology CLVS:US $ 112.69M 61.19M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Eli Lilly And LLY:US $ 13682M 1411.2M
Enanta Pharmaceuticals ENTA:US $ 36.17M 7.55M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
Glaxosmithkline GSK:US $ 22417M 1030M
Harsco HSC:US $ 578.28M 27.37M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Immunogen IMGN:US $ 111.78M 8.53M
Insmed INSM:US $ 112.5M 12.84M
Intrexon XON:US $ 28.99M 0.12M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Lannett LCI:US $ 112.28M 21.81M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Macrogenics MGNX:US $ 68.86M 1.06M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Sangamo Biosciences SGMO:US $ 131.9M 5.04M
Spectrum Pharmaceuticals SPPI:US $ 57.27M 0.57M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
Veracyte VCYT:US $ 50.04M 13.93M